Fostamatinib for warm antibody autoimmune hemolytic anemia: Phase 3, randomized, double‐blind, placebo‐controlled, global study (FORWARD)
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fostamatinib for warm antibody autoimmune hemolytic anemia: Phase 3, randomized, double‐blind, placebo‐controlled, global study (FORWARD)
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HEMATOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-11-06
DOI
10.1002/ajh.27144
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open‐label study
- (2022) David J. Kuter et al. AMERICAN JOURNAL OF HEMATOLOGY
- New Therapies for the Treatment of Warm Autoimmune Hemolytic Anemia
- (2022) Bruno Fattizzo et al. TRANSFUSION MEDICINE REVIEWS
- Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib
- (2022) Nichola Cooper et al. PLATELETS
- How I treat warm autoimmune hemolytic anemia
- (2021) Wilma Barcellini et al. BLOOD
- Complement receptor 3 mediates both sinking phagocytosis and phagocytic cup formation via distinct mechanisms
- (2021) Stefan Walbaum et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Changing Landscape of Autoimmune Hemolytic Anemia
- (2020) Wilma Barcellini et al. Frontiers in Immunology
- Autoimmune hemolytic anemia: current knowledge and perspectives
- (2020) Sylwia Sulimiera Michalak et al. Immunity & Ageing
- Long‐term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program
- (2019) James B. Bussel et al. AMERICAN JOURNAL OF HEMATOLOGY
- Warm Autoimmune Hemolytic Anemia
- (2019) Robert A. Brodsky NEW ENGLAND JOURNAL OF MEDICINE
- Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting
- (2019) Ulrich Jäger et al. BLOOD REVIEWS
- Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials
- (2018) James Bussel et al. AMERICAN JOURNAL OF HEMATOLOGY
- Current and emerging treatment options for autoimmune hemolytic anemia
- (2018) Wilma Barcellini et al. Expert Review of Clinical Immunology
- Venous thromboembolic events during warm autoimmune hemolytic anemia
- (2018) Sylvain Audia et al. PLoS One
- The role of rituximab in adults with warm antibody autoimmune hemolytic anemia
- (2015) D. Dierickx et al. BLOOD
- Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia
- (2015) W. Barcellini et al. DISEASE MARKERS
- Syk Tyrosine Kinase Is Critical for B Cell Antibody Responses and Memory B Cell Survival
- (2015) Jochen A. Ackermann et al. JOURNAL OF IMMUNOLOGY
- New Insights in the Pathogenesis of Autoimmune Hemolytic Anemia
- (2015) Wilma Barcellini TRANSFUSION MEDICINE AND HEMOTHERAPY
- Characteristics and outcome of warm autoimmune hemolytic anemia in adults: New insights based on a single-center experience with 60 patients
- (2014) Mathilde Roumier et al. AMERICAN JOURNAL OF HEMATOLOGY
- OSKIRA-4: a phase IIb randomised, placebo-controlled study of the efficacy and safety of fostamatinib monotherapy
- (2014) Peter C Taylor et al. ANNALS OF THE RHEUMATIC DISEASES
- Pharmacokinetic-pharmacodynamic modeling of fostamatinib efficacy on ACR20 to support dose selection in patients with rheumatoid arthritis (RA)
- (2014) John Maringwa et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of Fostamatinib, an Oral Spleen Tyrosine Kinase Inhibitor, in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate: Results From a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
- (2014) Michael E. Weinblatt et al. Arthritis & Rheumatology
- A phase III randomized trial comparing glucocorticoid monotherapyversusglucocorticoid and rituximab in patients with autoimmune haemolytic anaemia
- (2013) Henrik Birgens et al. BRITISH JOURNAL OF HAEMATOLOGY
- Effects of Fostamatinib (R788), an Oral Spleen Tyrosine Kinase Inhibitor, on Health-related Quality of Life in Patients with Active Rheumatoid Arthritis: Analyses of Patient-reported Outcomes from a Randomized, Double-blind, Placebo-controlled Trial
- (2013) M. E. Weinblatt et al. JOURNAL OF RHEUMATOLOGY
- Fostamatinib, a Syk-Kinase Inhibitor, Does Not Affect Methotrexate Pharmacokinetics in Patients With Rheumatoid Arthritis
- (2011) Muhammad Baluom et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Warm Autoimmune Hemolytic Anemia: Recent Progress in Understanding the Immunobiology and the Treatment
- (2010) Melca M.O. Barros et al. TRANSFUSION MEDICINE REVIEWS
- Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk
- (2008) A. Podolanczuk et al. BLOOD
- Hemolytic anemia due to warm autoantibodies
- (2007) Charles H. Packman BLOOD REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now